$TOMDF News

Last published 2y ago

2y agoTOMDFTodos Medical Announces Insolvency Proceedings in IsraelGlobeNewswireNEW YORK, NY, ALPHARETTA, GA and TEL AVIV, Israel, Dec. 22, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB:TOMDF), an innovative healthcare solutions company, today announced that a trustee was
3y agoTOMDFTodos Medical Provides Corporate Update: Retooling to Focus on Long COVID EpidemicGlobeNewswireNEW YORK, NY, ALPHARETTA, GA and TEL AVIV, ISRAEL, Sept. 26, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire - Todos Medical, Ltd. (OTCQB:TOMDF), an innovative healthcare solutions company, today provided a corporate update
3y agoTOMDFTodos Announces Notice of Allowance From USPTO for Patent Application Covering Use of Compositions In Tollovid™ and Tollovir™ IngredientsGlobeNewswireClaims covering inhibition of 3CL protease, inflammation and autophagy underscore Dr. Dorit Arad's lifelong work NEW YORK, NY, ALPHARETTA, GA and TEL AVIV, ISRAEL, Aug. 30, 2023 (GLOBE NEWSWIRE) -- via
3y agoTOMDFTodos Medical Enters Into Letter of Intent for Provista Diagnostics to License PCR-based Sepsis Diagnostic Test AcuSept LDT Rights From Acumen DiagnosticsGlobeNewswireNew York, NY, Alpharetta, GA, Tel Aviv, ISRAEL and SINGAPORE, March 28, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Todos Medical, Ltd. (OTCQB:TOMDF), a comprehensive medical diagnostics and related solutions company,
3y agoTOMDFTodos Medical Begins Trading on the OTC Pink MarketplaceGlobeNewswireNew York, NY, Alpharetta, GA, Tel Aviv, ISRAEL, March 27, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Todos Medical, Ltd. (OTCQB:TOMDF), a comprehensive medical diagnostics and related solutions company, today
3y agoTOMDFTodos Medical Supports Long COVID Awareness DayGlobeNewswireNEW YORK, NY, ALPHARETTA, GA and TEL AVIV, ISRAEL, March 15, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Todos Medical, Ltd. (OTCQB:TOMDF), a comprehensive medical diagnostics and related solutions company, today
3y agoTOMDFTodos Medical Enters Into Moratorium on Conversions Agreement With Convertible Note HoldersGlobeNewswireMoratorium Goes Into Effect After Market Close on March 13, 2023 NEW YORK, NY, ALPHARETTA, GA and TEL AVIV, ISRAEL, March 13, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Todos Medical, Ltd. (OTCQB:TOMDF), a
3y agoTOMDFTodos Medical Provides Corporate UpdateGlobeNewswireNew York, NY, and Tel Aviv, ISRAEL, Feb. 23, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB:TOMDF), a comprehensive medical diagnostics and related solutions company, today provided a corporate
3y agoTOMDFTodos Medical Initiates Validation Plan for PCR-based Avian Influenza A (H5N1, Bird Flu) Test at CLIA/CAP Testing Lab Provista DiagnosticsGlobeNewswireNew York, NY, and Tel Aviv, ISRAEL, Feb. 14, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB:TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that its
3y agoTOMDFTodos Medical to Present at the RHK 2022 Disruptive Growth ConferenceGlobeNewswireNew York, NY, and Tel Aviv, ISRAEL, Dec. 06, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB:TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that its
3y agoTOMDFTodos Medical's 3CL Pharma Awarded Oral and Poster Presentations at World Antiviral Congress 2022GlobeNewswireNew York, NY, and Tel Aviv, ISRAEL, Nov. 29, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB:TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that its
3y agoTOMDFTodos Medical to Attend World Antiviral CongressGlobeNewswireNew York, NY, and Tel Aviv, ISRAEL, Nov. 22, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB:TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that
3y agoTOMDFTodos Medical Enters Into Exclusive Worldwide Automated Retail Supply Agreement With Smart Automated Retail NetworkGlobeNewswireAffy Services, Smart Automated Retail Network Parent Company, to Also Represent Todos for Traditional Shelf Space to Its 20,000+ US-based Retail Grocery Store Locations NEW YORK, NY, and TEL AVIV, ISRAEL, Nov. 16,
3y agoTOMDFTodos Medical Announces Third Quarter 2022 Financial ResultsGlobeNewswire§ 89% increase in Q3/2022 quarterly revenues as compared with Q3/2021 § Earnings and business update call to be held at 8:30am ET on November 15, 2022 New York, NY, and Tel Aviv, ISRAEL, Nov. 15, 2022 (GLOBE
3y agoTOMDFTodos Medical to Host Third Quarter 2022 Earnings and Business Update Conference Call on November 15, 2022GlobeNewswireNEW YORK, NY, AND TEL AVIV, ISRAEL, Nov. 14, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Todos Medical, Ltd. (OTCQB:TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that it
4y agoTOMDFTodos Medical Terminates Tollovid™ Products License & Distribution Agreement with T-Cell Protect Hellas S.A.GlobeNewswireNew York, NY, and Tel Aviv, ISRAEL, Nov. 10, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB:TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that it
4y agoTOMDFTodos Medical Announces BioFuture™ NYC 2022 PresentationGlobeNewswireNew York, NY, and Tel Aviv, ISRAEL, Nov. 04, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB:TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that its
4y agoTOMDFTodos Medical CLIA/CAP Lab Provista Submits Emergency Use Authorization Application for MonkeyPox PCR Test to US FDAGlobeNewswireNew York, NY, and Tel Aviv, ISRAEL, Oct. 14, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire --Todos Medical, Ltd. (OTCQB:TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that its
4y agoTOMDFTodos Medical Provides Corporate UpdateGlobeNewswire3CL Pharma prepares to crowdfund for Long COVID trials of Tollovir™ and Tollovid™CEO to Present at Emerging Growth Conference on Wednesday, October 12, 2022 at 2pm ET New York, NY, and Tel Aviv, ISRAEL,
4y agoFLES FNGR MMNGF NEXCF+2Presenting on the Emerging Growth Conference on October 12 Register NowGlobeNewswireMIAMI, Oct. 11, 2022 (GLOBE NEWSWIRE) -- EmergingGrowth.com, a leading independent small cap media portal with an extensive history of providing unparalleled content for the Emerging Growth Companies and Markets,
4y agoSTEK TOMDFROTH Capital Partners to Host Inaugural Healthcare Opportunities Conference on October 6th at the Yale Club in New York CityGlobeNewswireNEWPORT BEACH, Calif., Oct. 04, 2022 (GLOBE NEWSWIRE) -- via InvestorWire -- ROTH Capital Partners (ROTH), www.roth.com, a full service investment bank focused on serving emerging growth companies and their investors, today announced that it will host
4y agoTOMDFTodos Medical Receives Two Notices of Allowance from USPTO for AI-Based TBIA Pan-Cancer Blood Diagnostics PlatformGlobeNewswireNew York, NY, and Tel Aviv, ISRAEL, Sept. 30, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB:TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that it has received two Notices of Allowan
4y agoTOMDFTodos Medical Announces USPTO Trademark Notice of Allowance for 3CL Protease Biomarker Diagnostics TolloTest™GlobeNewswireNew York, NY, and Tel Aviv, ISRAEL, Sept. 27, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB:TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that its majority-owned joint venture 3CL
4y agoTOMDFTodos Medical Enters Into $50M Contract to Supply Tollovid™ and CBD Products to Retail Distributor Company Nerd HempGlobeNewswire5500 Automated Retail Machines to be Rolled out in Q4/22 and Q1/23 $11.5M in Q4/22 Revenue Expected From This Agreement NEW YORK, NY and TEL AVIV, ISRAEL, Sept. 22, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Todos Medical, Ltd. (OTCQB:TOMD
4y agoTOMDFTodos Medical Announces NFL Hall of Famer Michael Irvin as Tollovid™ Sports Ambassador for #TolloUp CampaignGlobeNewswireNEW YORK, NY and Tel Aviv, ISRAEL, Sept. 16, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Todos Medical, Ltd. (OTCQB:TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that Michael Irvin has agreed to become the
4y agoTOMDFTodos Medical Announces Preprint of Long COVID Case Study Participant with Confirmed Microclot and Hyperactivated Platelets who Benefitted from TollovidGlobeNewswireNew York, NY, and Tel Aviv, ISRAEL, Sept. 15, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB:TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that its majority-owned joint venture 3CL P
4y agoTOMDFTodos Medical Initiates Validation Plan for PCR-based Polio Testing at CLIA/CAP Laboratory Provista DiagnosticsGlobeNewswireFollows CDC & World Health Organization's (WHO) announcement that US now meets criteria for country with circulating vaccine-derived poliovirus (cVDPV) Surveillance wastewater and patient diagnostics testing planned New York,
4y agoTOMDFTodos Medical & The Alchemist's Kitchen to Host "Long COVID: An Integrated Approach" Event Benefitting Survivor CorpsGlobeNewswireNew York, NY, and Tel Aviv, ISRAEL, Sept. 13, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB:TOMDF), a comprehensive medical diagnostics and related solutions company, together with The Alchemist's Kitchen based in the SoHo di
4y agoTOMDFTodos Medical's 3CL Protease Inhibitor Supplement Tollovid™ Featured in Wellness MagazineGlobeNewswireNew York, NY, and Tel Aviv, ISRAEL, Sept. 13, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB:TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that Wellness Magazine has published an ar
4y agoTOMDFTodos Medical Partner NLC Pharma Assigns IP for Tollovir™, Tollovid™, and TolloTest™ into JV 3CL PharmaGlobeNewswire3CL Pharma preparing crowdfunding to fund Tollovir EUA filing in hospitalized COVID patients and Tollovir, Tollovid and TolloTest clinical development for Long COVID Funding also to be used to support US national marketing campaign for Tollovid sales
4y agoTOMDFTodos Medical CEO Discusses Long COVID Economic Impact with Moneta Advisory Managing Partner Marc LoPrestiGlobeNewswireNew York, NY, and Tel Aviv, ISRAEL, Sept. 09, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB:TOMDF), a comprehensive medical diagnostics and related solutions company, today released the Nasdaq MarketSite interview between Mon
4y agoTOMDFTodos Medical Announce Kingcarlx as Brand Ambassador for the Tollovid #TolloUp Lifestyle CampaignGlobeNewswireCompany also retains B2i Digital to enhance engagement with the investor community New York, NY, and Tel Aviv, ISRAEL, Sept. 02, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB:TOMDF), a comprehensive medical diagnostics
4y agoTOMDFTodos Medical Establishes Botanical Supplement Manufacturing Capabilities to Support Tollovid Global Expansion and Initiates CBD-A ProductionGlobeNewswireNew York, NY, and Tel Aviv, ISRAEL, Aug. 31, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire --Todos Medical, Ltd. (OTCQB:TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that it has entered into a lease agreement i
4y agoTOMDFTodos Medical Expands COVID Onsite School Sample Collection to Include MonkeyPox TestingGlobeNewswireNew York, NY, and Tel Aviv, ISRAEL, Aug. 29, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB:TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that its Atlanta-area CLIA/CAP-certified c
4y agoTOMDFTodos Medical Announces Saliva-Only MonkeyPox Testing at CLIA/CAP Clinical Lab Provista DiagnosticsGlobeNewswireLab Reaching Out to Georgia-based School Administrators to Assist with Outbreak Plans NEW YORK, NY and TEL AVIV, Israel, Aug. 26, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Todos Medical, Ltd. (OTCQB:TOMDF), a comprehensive medical diagno
4y agoTOMDFTodos Medical Enrolls Female Long COVID Patient Unable to Secure Testing While Symptomatic for MonkeyPox into Provista Diagnostics Case Study SeriesGlobeNewswirePatient denied testing for weeks due to risk of physician infection & non-MSM status Amerimmune Long COVID Panel and Provista research-use-only MonkeyPox assays to assess effect of TPoxx intervention on Long COVID and MonkeyPox biomarkers Risk of
4y agoTOMDFTodos Medical Initiates MonkeyPox Diagnostic Case Studies After Being Approached by 4 Patients, Including 3 WomenGlobeNewswireNew York, NY, and Tel Aviv, ISRAEL, Aug. 23, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB:TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that its Atlanta-area CLIA/CAP-certified
4y agoTOMDFTodos Medical Reports Second Quarter 2022 Financial Results and Business Update Conference Call on Tuesday, August 23 at 8:30am ETGlobeNewswirePreparations for Tollovir™ Phase 2 Trial Extension to Support EUA Filing Now Complete Preparations for Tollovid™ Phase 2 Trial in Long COVID Now Complete Launch of New Suite of PCR Tests at Provista Underway, Including MonkeyPox Saliva Testin
4y agoTOMDFTodos Medical Announces Commercialization of Lesion and Saliva-Based MonkeyPox PCR TestingGlobeNewswireProvista begins validation preparations for blood-based IgM/IgG MonkeyPox LDT Company to release its Q2/2022 10Q quarterly report at 4:05 pm ET this afternoon Company to host business update conference call on Tuesday, August 23rd at 8:30 am ET Ne
4y agoTOMDFTodos Medical Announces Preprint of Data from First 100 Participants in IRB-waived Market Research Study of Supplementation with Tollovid in Long COVIDGlobeNewswireNew York, NY, and Tel Aviv, ISRAEL, Aug. 19, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB:TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that its majority-owned joint venture 3CL
4y agoTOMDFTodos Medical Reports Pre-Print of Publication Detailing Tollovid Supplementation Following COVID-19 mRNA Vaccination in Long COVIDGlobeNewswireNew York, NY, and Tel Aviv, ISRAEL, Aug. 15, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB:TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that its majority-owned joint venture 3CL
4y agoTOMDFTodos Medical Completes Trial Design for Tollovid™ Long COVID Clinical Study in AdultsGlobeNewswire§ 3-arm randomized, controlled study to evaluate 15-day and 30-day treatment regimens § Finalizing contracts with two Long COVID clinics to recruit patients § Institutional Review Board (IRB) protocol submission imminent New York, NY
4y agoTOMDFTodos Medical Announces PCR Validation of Wound and Respiratory Pathogen Panels at CLIA/CAP Lab Provista DiagnosticsGlobeNewswireNew York, NY, and Tel Aviv, ISRAEL , Aug. 10, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB:TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that its CLIA/CAP-certified laboratory
4y agoTOMDFTodos Medical Announces First Two Contracts for PCR-based MonkeyPox Testing at CLIA/CAP Clinical Testing Laboratory Provista DiagnosticsGlobeNewswireNew York, NY, and Tel Aviv, ISRAEL, Aug. 08, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB:TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that its CLIA/CAP-certified laboratory Pr
4y agoTOMDFTodos Medical Announces First Long COVID Clinic Laboratory Services Agreement for Long COVID Panel Biomarker Partnership with Amerimmune DiagnosticsGlobeNewswireRTHM collaborating on Tollovid™ 3CL inhibitor immune support supplement case studies Tollovid biomarker data to support potential structure-function claims in Long COVID New York, NY, and Tel Aviv, ISRAEL, Aug. 05, 2022 (GLOBE NEW
4y agoTOMDFTodos Medical Initiates Validation Plan for PCR-based MonkeyPox Test at CLIA/CAP Clinical Testing Laboratory Provista DiagnosticsGlobeNewswire§ Lesion swab (standard of care) and saliva-based sample collection planned § Peer-reviewed publication demonstrating saliva testing sensitivity opens door for asymptomatic testing New York, NY, and Tel Aviv, ISRAEL, Aug. 03, 2022
4y agoTOMDFTodos Medical Announces Preprint of Acute COVID-19 Paxlovid Rebound Rescued by TollovidGlobeNewswireNew York, NY, and Tel Aviv, ISRAEL, Aug. 01, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB:TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that its majority-owned joint venture 3CL
4y agoTOMDFTodos Medical Partners with Amerimmune Diagnostics on Long COVID Biomarker PanelGlobeNewswireNEW YORK, NY, AND TEL AVIV, ISRAEL, July 28, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Todos Medical, Ltd. (OTCQB:TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that its CLIA/CAP certified clinical labora
4y agoTOMDFTodos Medical Announces Preprint of Chronic Long COVID Case Study #8 of Paxlovid® Treatment Followed by Tollovid™ Dietary SupplementationGlobeNewswireNew York, NY, and Tel Aviv, ISRAEL, July 22, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB:TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that its majority-owned joint venture 3CL
4y agoTOMDFTodos Medical Reports Case Study #7 in Acute and Long COVIDGlobeNewswireNew York, NY, and Tel Aviv, ISRAEL, July 12, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire --Todos Medical, Ltd. (OTCQB:TOMDF), a comprehensive medical diagnostics and related solutions company, today announced that its majority-owned joint venture 3CL P